B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer

Cancer Letters

Volumn 318, Issue 1, 2012, Pages 86-92

  Singh Gupta, Vinita ^a   Banerjee, Sanjeev ^a   Yunker, Christopher K ^a   Rakowski, Joseph T ^a   Joiner, Michael C ^a   Konski, Andre A ^a   Sarkar, Fazlul H ^a   Hillman, Gilda G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen receptor; B DIM; Prostate cancer; Radiation

Indexed keywords

3,3' DIINDOLYLMETHANE; ANDROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CELL KILLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDOLES; MALE; MICE; MICE, NUDE; NF-KAPPA B; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; X-RAYS;

MUS MUSCULUS;

EID: 84857139314     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.12.006     Document Type: Article

References (19)

1. Sarkar F.H., Li Y Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res. 2006, 66:3347-3350.
2. Banerjee S., Kong D., Wang Z., Bao B., Hillman G.G., Sarkar F.H. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic. Mutat. Res. 2011, 728:47-66.
3. Hillman G.G., Singh-Gupta V. Soy isoflavones sensitize cancer cells to radiotherapy. Free Radic. Biol. Med. 2011, 51:289-298.
4. Hebert J.R., Hurley T.G., Olendzki B.C., Teas J., Ma Y., Hampl J.S. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J. Natl. Cancer Inst. 1998, 90:1637-1647.
5. Kristal A.R., Lampe J.W. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr. Cancer 2002, 42:1-9.
6. Bhuiyan M.M., Li Y., Banerjee S., Ahmed F., Wang Z., Ali S., Sarkar F.H. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res. 2006, 66:10064-10072.
7. Heath E.I., Heilbrun L.K., Li J., Vaishampayan U., Harper F., Pemberton P., Sarkar F.H. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am. J. Trans. Res. 2010, 2:402-411.
8. A. Jemal, R. Siegel, J. Xu, E. Ward. Cancer statistics, 2010. CA Cancer J. Clin. 60 (2010) 277-300.
9. Swanson G.P., Hussey M.A., Tangen C.M., Chin J., Messing E., Canby-Hagino E., Forman J.D., Thompson I.M., Crawford E.D. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J. Clin. Oncol. 2007, 25:2225-2229.
10. Morgan P.B., Hanlon A.L., Horwitz E.M., Buyyounouski M.K., Uzzo R.G., Pollack A. Radiation dose and late failures in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:1074-1081.
11. Heinlein C.A., Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 2004, 25:276-308.
12. Dehm S.M., Tindall D.J. Molecular regulation of androgen action in prostate cancer. J. Cell Biochem. 2006, 99:333-344.
13. Zhang L., Charron M., Wright W.W., Chatterjee B., Song C.S., Roy A.K., Brown T.R. Nuclear factor-kappa B activates transcription of the androgen receptor gene in Sertoli cells isolated from testes of adult rats. Endocrinology 2004, 145:781-789.
14. Singh-Gupta V., Zhang H., Yunker C.K., Ahmad Z., Zwier D., Sarkar F.H., Hillman G.G. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy. Pharm. Res. 2010, 27:1115-1127.
15. Singh-Gupta V., Zhang H., Banerjee S., Kong D., Raffoul J.J., Sarkar F.H., Hillman G.G. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int. J. Cancer 2009, 124:1675-1684.
16. Nachshon-Kedmi M., Yannai S., Haj A., Fares F.A. Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem. Toxicol. 2003, 41:745-752.
17. Raffoul J.J., Banerjee S., Singh-Gupta V., Knoll Z.E., Fite A., Zhang H., Abrams J., Sarkar F.H., Hillman G.G. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res. 2007, 67:2141-2149.
18. Harashima K., Akimoto T., Nonaka T., Tsuzuki K., Mitsuhashi N., Nakano T. Heat shock protein 90 (Hsp90) chaperone complex inhibitor, radicicol, potentiated radiation-induced cell killing in a hormone-sensitive prostate cancer cell line through degradation of the androgen receptor. Int. J. Radiat. Biol. 2005, 81:63-76.
19. Udayakumar T.S., Hachem P., Ahmed M.M., Agrawal S., Pollack A. Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive and androgen-insensitive prostate cancer cells to radiation. Mol. Cancer Res. 2008, 6:1742-1754.